Biotech Checkpoint Therapeutics Announces $7.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules December 15, 2022
Biotech CASI PHARMACEUTICALS’ PARTNER JUVENTAS ANNOUNCES NEW DRUG APPLICATION FOR CNCT19 ACCEPTED BY CHINA NATIONAL MEDICAL PRODUCTS ADMINISTRATION December 15, 2022
Biotech Genprex Strengthens Diabetes Gene Therapy Program with License of Additional Technology from University of Pittsburgh December 15, 2022
Biotech ASLAN Pharmaceuticals Announces First Patient Screened in Study of Eblasakimab in Dupilumab Experienced Atopic Dermatitis Patients December 15, 2022
Biotech CLASS ACTION UPDATE for EIGR, VERU and TWST: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders December 14, 2022
Biotech Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) Announces Receipt of Extension to Meet the Nasdaq’s Minimum Bid Price Requirement December 14, 2022
Biotech ROSEN, SKILLED INVESTOR COUNSEL, Encourages Eiger BioPharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – EIGR December 14, 2022
Biotech DEADLINE ALERT: Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 9, 2023 in Eiger Lawsuit – EIGR December 14, 2022